Skip to main content
Michael Boeckh, MD, Infectious Disease, Seattle, WA

Michael J Boeckh MD

Infectious Disease•Seattle, WA

Professor, Medicine, University of Washington School of Medicine

Join to View Full Profile

  • 1100 Fairview Ave NSeattle, WA 98109

  • Phone+1 206-667-4898

  • Fax+1 206-520-5620

Dr. Boeckh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Boeckh's Full ProfileAlready have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 1990 - 1992
  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 1985

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1993 - 2026

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • RNA Sequencing of the in Vivo Human Herpesvirus 6B Transcriptome to Identify Targets for Clinical Assays Distinguishing Between Latent and Active Infections  
    Joshua A Hill, Keith R Jerome, Michael Boeckh, mBio

Abstracts/Posters

  • Freesia Study Design: JNJ-53718678 in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
    Michael Boeckh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis
    Michael Boeckh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Experts Urge Clinical Trials Network to Study Infectious Disease Therapies in Immunocompromised Patients
    Experts Urge Clinical Trials Network to Study Infectious Disease Therapies in Immunocompromised PatientsSeptember 23rd, 2025
  • New Horizons in Infectious Disease Treatment and Prevention in Immunocompromised Patients
    New Horizons in Infectious Disease Treatment and Prevention in Immunocompromised PatientsJune 23rd, 2025
  • Infectious Disease Scientists Look Beyond the Pandemic
    Infectious Disease Scientists Look Beyond the PandemicMay 9th, 2023
  • Join now to see all

Grant Support

  • 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and SepsisFRED HUTCHINSON CANCER CENTER2020–2027
  • Training Program in Infectious Diseases in the Immunocompromised HostFRED HUTCHINSON CANCER CENTER2016–2026
  • A Randomzied Phase II Trial Of CMV Prevention In Acute Lung InjuryNational Heart, Lung, And Blood Institute2010–2011
  • Infections In Hematopoietic Cell Transplant RecipientsNational Heart, Lung, And Blood Institute2009–2011
  • Microbiology And Virology CoreNational Cancer Institute2007–2011
  • Respiratory Viruses And Airflow Obstruction After HCTNational Heart, Lung, And Blood Institute2005–2008
  • Core--Microbiology And VirologyNational Cancer Institute2002
  • CMV And HIV SheddingEunice Kennedy Shriver National Institute Of Child Health &Human Development2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Michael Boeckh, Dr. Michael Boeckh, MD, Dr. M Boeckh, Dr. Michael J Boeckh